The largest database of trusted experimental protocols

Chromogen 3 amino 9 ethylcarbazole

Manufactured by Merck Group
Sourced in United States, Germany

Chromogen 3-amino-9-ethylcarbazole is a laboratory reagent used in various immunohistochemical and enzymatic assays. It functions as a chromogen, which is a dye-forming compound that reacts with specific enzymes to produce a colored product. The colored product can then be visualized and analyzed using appropriate laboratory equipment and techniques.

Automatically generated - may contain errors

8 protocols using chromogen 3 amino 9 ethylcarbazole

1

Immunohistochemical staining protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Staining was performed with antibody targeting C/EBPδ, LCN2, DEFB4, and S100A7 (Table S1). According to the primary antibody species, either biotin-labeled horse anti-mouse antibodies (Vector Laboratories, Burlingame, CA, U.S.A.) or biotin-labeled rabbit anti-goat antibodies (Vector Laboratories, Burlingame, CA, U.S.A.) were amplified with avidin-biotin complex (Vector Laboratories) and developed using chromogen 3-amino-9-ethylcarbazole (Sigma Aldrich, St Louis, MO, U.S.A.).
+ Open protocol
+ Expand
2

Immunodetection of Human IL-32 Isoforms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard procedures were used for immunohistochemistry and immunofluorescence as previously described (11 (link)). Frozen tissue sections were stained with mouse anti-human IL-32αβγδ (KU32–52, BioLegend). Biotin-labeled horse anti-mouse antibody (Vector Laboratories) was used to detect mouse monoclonal antibody. The staining signal was amplified with avidin-biotin complex (Vector Laboratories) and developed with chromogen 3-amino-9-ethylcarbazole (Sigma-Aldrich).
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen sections of skin biopsies were dried at room temperature and then fixed for 2 minutes in acetone. Next, the samples were blocked with 10% normal serum of the species in which the secondary antibody was made and then the samples were incubated overnight at 4°C with the appropriate primary antibody. Biotin-labeled secondary antibodies (Vector Laboratories, Burlingame, CA) were amplified with avidin-biotin complex (Vector Laboratories) and developed with chromogen 3-amino-9-ethylcarbazole (Sigma Aldrich, St. Louis, MO) to produce a red color indicative of positive staining.
Primary antibodies used in this study are as follows (all are mouse monoclonal): IL10 (Life Technologies, Clone 945A2A5, IgG1, 1:50 dilution), CD95 (FAS) (BD Biosciences, Clone DX2, IgG1, 1:50), LAG3 (Enzo Life Sciences, Clone 17B4, IgG1, 1:50), PD1 (eBioscience, Clone MIH4, IgG1, 1:50), PDL1 (eBioscience, Clone MIH1, IgG1, 1:50), PDL2 (eBioscience, Clone MIH18, IgG1, 1:100), IDO1 (LifeSpan Biosciences, Inc., Clone 10.1, IgG3, 1:100), and CTLA4 (abcam, Clone BNI3, IgG2a, 1:100).
+ Open protocol
+ Expand
4

Immunohistochemical Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Staining was performed with antibody targeting C/EBPβ, LCN2, HBD2, STAT1, RFX5 (Table S2). According to the primary antibody species, either biotin-labeled horse anti-mouse antibodies (Vector Laboratories, Burlingame, CA, U.S.A.) or biotin-labeled rabbit anti-goat antibodies (Vector Laboratories, Burlingame, CA, U.S.A.) were amplified with avidin-biotin complex (Vector Laboratories) and developed using chromogen 3-amino-9-ethylcarbazole (Sigma Aldrich, St Louis, MO, U.S.A.). For the staining in the RHE, a black line denotes the dermoepidermal junction. Appropriate negative controls were used.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Zr-89 PET/CT Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunohistochemical analysis, the PET/CT imaging and biodistribution cohort (n=6) tumors were used. Tumor ipsilateral right brain and contralateral left-brain samples were fixed in neutral phosphate-buffered 10% formalin (Fisher Scientific, Pittsburgh, PA) for 24 h. Samples were then transferred to 70% ethanol until the Zr-89 decayed (>5 half-lives). Samples were dehydrated using an EtOH gradient of 70% to 100% over 24 h, cleared with histology grade xylene (Fisher Scientific), embedded in granular paraffin, and sectioned (5 μm) on poly-lysine slides. Sections were incubated with 10% normal goat serum, and then overnight at 4°C with primary antibody. Biotinylated secondary goat anti-rabbit Ab (Abcam; dilution 1:200) was used to detect the primary Ab. The staining signal was amplified with avidin-biotin complex (Vector Laboratories, Burlingame, CA) and developed using chromogen 3-amino-9-ethylcarbazole (Sigma-Aldrich). ImageJ software (ImmunoRatio plugin) was used to quantify CD11b+ cells per nuclear area [20 (link)]. A histomorphologic analysis of the tumors was performed with the H&E slides.
+ Open protocol
+ Expand
6

ELISpot Assay for IFNγ Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISpot assays were carried out on Multiscreen HTS IP 0.45μm filter plates (Millipore Sigma). Briefly, the plates were coated with anti-IFNγ capture antibody (clone AN18, BioLegend) overnight at 4°C and blocked with RPMI-1640 supplemented with 20% FBS for 2 hours at 37°C. 500,000 splenocytes were then added, and the plates were incubated in the presence of 10 μg/ml of pooled peptides or 25 ng/ml of PMA and 0.5 μg/ml of Ionomycin in positive control wells, or 0.1% DMSO in negative control wells. In addition, for freeze-thawed splenocytes (Figure 7) 50 IU/ml of mouse IL-2 was added to the stimulation medium to enhance T cell survival. After incubating the plate for 44 hours at 37°C, the wells were washed to remove the cells. The wells were then incubated with biotinylated anti-IFNγ detection antibody (clone R4–6A2, BioLegend) for 2 hours at 37°C followed by streptavidin-HRP for 1 hour at room temperature. IFNγ spots were developed using 3-Amino-9-ethylcarbazole chromogen (Sigma) and images were captured by the ELISpot Reader (AID GmbH, Germany). Automatic spot counts were obtained using the AID ELISpot Reader software.
+ Open protocol
+ Expand
7

Quantifying IFN-gamma Producing Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISpot assays were carried out on Multiscreen HTS IP 0.45-μm filter plates (Millipore Sigma). Briefly, the plates were coated with anti-IFNγ capture antibody (clone AN18; BioLegend) overnight at 4°C and blocked with RPMI1640 supplemented with 20% FBS for 2 hours at 37°C. Then, 500,000 splenocytes were then added, and the plates were incubated in the presence of 10 μg/mL pooled peptides or 25 ng/mL PMA and 0.5 μg/mL ionomycin in positive control wells or 0.1% DMSO in negative control wells. In addition, for freeze-thawed splenocytes (Fig. 7), 50 IU/mL mouse IL2 was added to the stimulation medium to enhance T-cell survival. After incubating the plate for 44 hours at 37°C, the wells were washed to remove the cells. The wells were then incubated with biotinylated anti-IFNγ detection antibody (clone R4–6A2; BioLegend) for 2 hours at 37°C followed by streptavidin-HRP for 1 hour at room temperature. IFNγ spots were developed using 3-amino-9-ethylcarbazole chromogen (Sigma), and images were captured by the ELISpot Reader (AID GmbH, Germany). Automatic spot counts were obtained using the AID ELISpot Reader software.
+ Open protocol
+ Expand
8

Murine IFNγ ELISPOT Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse IFNγ ELISPOT assays were performed using the Ready-SET-Go! kit (eBioscience) on Multiscreen HTSIP Filter Plates (EMD Millipore). Briefly, plates were coated with anti-IFNγ capture antibody overnight and then blocked for 2 hours at 37°C with RPMI in 20% FBS. Fifty thousand negatively sorted CD8 + T cells were combined with 150,000 CD8- cells (flow-through) from vaccinated mice. Cells were incubated at 37°C for 24 hours with 5ug/mL of pooled peptides or 10 ug/mL of a single peptide. Positive control wells stimulated with phorbol 12-myristate 13-acetate (PMA) (25ng/mL) and Ionomycin (500ug/mL) (Sigma) and negative control DMSO-only (Sigma) wells were included on each plate. After overnight stimulation, the wells were decanted and incubated with biotinylated anti-mouse IFNγ primary antibody for 2 hours at 37°C, followed by Streptavidin-HRP antibody for 45 minutes. Spots were developed using 3-Amino-9-ethylcarbazole chromogen (Sigma) and washed extensively with tap water. After drying, plates were imaged and counted with the ImmunoSpot Analyzer (CTL, Cleveland, OH).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!